{
    "clinical_study": {
        "@rank": "73970", 
        "arm_group": [
            {
                "arm_group_label": "Milk protein", 
                "arm_group_type": "Experimental", 
                "description": "Study product will provide 25 g of protein to subjects. One single supplement will be taken."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is an exploratory study in order to determine whether the ingestion of one  type\n      of protein (milk protein/CHO/Fat) vs.placebo (CHO/Fat) 2 hours before bed time results in\n      the extension of the post-prandial window of anabolism during the night by increasing whole\n      body protein balance as well as muscle protein fractional synthesis rate (FSR)."
        }, 
        "brief_title": "Protein Intake on Muscle Protein Synthesis Overnight", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Protein Synthesis Overnight", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male\n\n          -  Healthy as determined by the medical questionnaire and the medical visit including\n             blood sampling\n\n          -  55-65y of age\n\n          -  BMI (19.0 - 25.0 kg/ m\u00b2)\n\n          -  Having signed the consent form\n\n        Exclusion Criteria:\n\n          -  Digestive (intestinal, gastric, hepatic or pancreatic), renal or metabolic disease,\n             as determined by the medical (screening) visit and a blood chemistry analysis\n             (glucose, total cholesterol, LDL, HDL, triglycerides, ASAT, ALAT, gamma GT, CRP,\n             creatinin)\n\n          -  Heart or other organ disease\n\n          -  Arterial hypertension (Systolic pressure \u2265 140 mmHg or diastolic pressure \u2265 90 mmHg)\n\n          -  Any clotting trouble (diagnosed by Prothrombin time (PT), activated Partial\n             Thromboplastin Time (aPTT), fibrinogen measures and platelets number (the latter is\n             part of a classical blood cells counting at screening)\n\n          -  Any inflammatory disease in the past four weeks\n\n          -  Use of specific medications\n\n          -  Recent major surgery (3 months)\n\n          -  History of major gastro-intestinal surgery (gastric bypass, intestinal resection\n             etc\u2026)\n\n          -  History of cancer within the past year\n\n          -  Significant weight loss during the last 3 months (5% and more)\n\n          -  Food allergies, especially cow milk protein allergies\n\n          -  Special diets especially vegetarian, high protein or weight loss program (anamnesis)\n\n          -  Smokers\n\n          -  High level structured exercise 3 times a week (e.g.: fitness club, competitions\u2026)\n\n          -  Have a high alcohol consumption (more than 2 drinks/day)\n\n          -  Consumption of illicit drugs anamnesis only\n\n          -  Having given blood within the last month, or willing to make a blood donation until\n             one month following the end of the study\n\n          -  Subject who cannot be expected to comply with the study procedures, including\n             consuming the test products.\n\n          -  Currently participating or having participated in another clinical trial during the\n             last month prior to the beginning of this study"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02041143", 
            "org_study_id": "13.19.MET"
        }, 
        "intervention": {
            "arm_group_label": "Milk protein", 
            "intervention_name": "Milk protein supplement", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 17, 2014", 
        "location": {
            "contact": {
                "email": "maurice.beaumont@rdls.nestle.com", 
                "last_name": "Maurice Beaumont, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Lausanne", 
                    "country": "Switzerland", 
                    "state": "Vaud", 
                    "zip": "1000"
                }, 
                "name": "Metabolic Unit"
            }, 
            "investigator": {
                "last_name": "Maurice Beaumont, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Protein Intake on Muscle Protein Synthesis and Whole Body Protein Balance During an Overnight Fast: an Exploratory Study", 
        "overall_contact": {
            "email": "maurice.beaumont@rdls.nestle.com", 
            "last_name": "Maurice Beaumont, MD"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Muscle protein FSR (fractional synthesis rate) will be determined using primed constant infusions of [13C6] phenylalanine for 5 hours starting around from 03:00 a.m. (see flow chart attached). Whole body protein balance will be measured throughout the night using [15N]glycine (200mg) which will be orally taken with the trial product in the evening.", 
            "measure": "muscle FSR determination", 
            "safety_issue": "No", 
            "time_frame": "Within 24 hours of product intake"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02041143"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Activation of signaling pathways involved in skeletal muscle protein balance will be assessed through use of immunohistochemistry", 
                "measure": "Activation of signaling pathways involved in skeletal muscle protein balance", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after product intake"
            }, 
            {
                "description": "Glucose metabolism will be assessed from circulating concentrations of glucose and insulin.", 
                "measure": "Glucose metabolism", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after product intake"
            }, 
            {
                "description": "The quantification of Free Amino Acids in Human Plasma will be done by Amino Acid Analyser Biochrom 30.", 
                "measure": "Plasma amino acid availability", 
                "safety_issue": "No", 
                "time_frame": "Within 24 hours after product intake"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}